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UCP3 is predominantly found associated with skeletal muscle
mitochondria [1–3], however it is still not clear what UCP3 actually
catalyzes in vivo. One constant is the physiological observation that
increased UCP3 protein expression levels are associated with
conditions where fatty acid oxidation is increased e.g. conditions
such as starvation and hyperthyroidism [2,4–7]. Several studies on
isolated skeletal muscle mitochondria suggest that UCP3 is an
uncoupler of oxidative phosphorylation either by being a catalyst
for fatty acid oxidation products from the mitochondrial matrix [8] or
by being activated to catalyze a proton leak by fatty acid oxidation
products such as 4-hydroxy-2-nonenal [9,10], although the speciﬁcity
of the latter has been challenged [11]. Interestingly, sequence analysis
and (pseudo)symmetry modeling based on known mitochondrial
transporters, predict that UCPs are keto-acid transporters [12]. UCP3
protein has also been detected in highly metabolic tissues such asbrown fat tissue [13,14] and heart [15], and in skeletal muscle under
conditions of high fat diet [16]. However, data from UCP3 knock-out
mice show no obvious metabolic phenotype compared to wild-types
[17,18].
Interestingly, UCP1, UCP2 and UCP3 proteins are found in various
immune cells. UCP1 is present in thymocytes and lack of UCP1 has
been shown to affect T-lymphocyte selection [19–22]. UCP2 is
predominantly found associated with macrophages and the innate
immune system, with UCP2 deﬁcient mice, for instance, being
proinﬂammatory and resistant to infection by Toxoplasma gondii
[23–25], while lack of UCP2 has minimal effect on thymocyte proﬁle
[26]. UCP3 has been detected inmitochondria from rat thymus and rat
spleen [14] and in this study we investigate the role of UCP3 in
thymocyte and T-lymphocyte selection.
The thymus is the site of thymocyte maturation and selection
resulting in naïve T-cells whichmigrate to peripheral lymphoid tissue,
such as spleen (for reviews see [26–28]). Thymocytes in the thymus
are at different stages of maturation. Themost immature of these cells
are easily identiﬁed due to the lack of the CD4/CD8 surface antigens
(CD4/CD8 double negatives DN) and account for up to ~5% of the cells
present in the thymus. Maturation manifests itself as expression of
both CD4 and CD8 antigens of the thymocyte surface (CD4/CD8
double positives (DP)), which account for up to 85% of cells in the
thymus. The DP cells undergo positive selection for antigen and
negative selection for self-antigen resulting in death of up to 95% of
these cells through apoptosis. The remaining DP cells mature to either
naïve CD4 single positive (CD4 SP) or naïve CD8 single positive
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migrating to the peripheral immune tissues. In the spleen, CD4 SP
T-lymphocytes account for approximately 20% of all cells whereas
CD8 SP T-lymphocytes account for approximately 10% of all cells. The
remainder of the cells in the spleen are composed mainly of reticu-
locytes, monocytes and B-lymphocytes with a negligible number of
CD4/CD8 DP T-lymphocytes [29,30]. In this study we investigated
whether there was UCP3 expression in thymus and spleen of mice,
whether lack of UCP3 in thymus and spleen results in a difference in
thymus and spleen cell composition proﬁle and function when com-
pared to wild-type mice of the same background, sex, age and strain.
2. Material and methods
2.1. Reagents
All reagents and chemicals used were of analytical grade where
possible and were obtained from Sigma Chemical Co. Ltd, Fancy Rd.,
Poole, Dorset, U.K. unless otherwise stated.
2.2. Animal source
UCP3−/−mice on a 129 background, originally provided by Prof.
Padraic Fallon (Institute of Molecular Medicine, Trinity College Health
Sciences Centre, St James' Hospital, Dublin) were bred in-house.
Animals were housed in a speciﬁc pathogen free environment. Wild-
type 129 mice and UCP3−/− were housed at 25±1 °C. All animals
were allowed free access to food (except those on a 24 h starvation
regime) and water and a 12-hour light/dark cycle was in place. All
mice were killed by CO2 asphyxiation.
2.3. Cell isolation
Thymocytes were isolated from UCP3−/− and wild type mice
essentially as described by Buttgereit and Brand [31]. The thymus was
removed, trimmed clean of connective tissue and brown fat (if present)
and transferred into Hanks' Balanced Salt Solution (Sigma) containing
10% (w/v) fetal bovine serum (FBS). A single cell suspension was
prepared by passage through a 70 μm nylon sieve (Falcon).
Spleen cellswere isolated according to themethod ofMills et al. [29].
The spleen was removed from the abdominal cavity, trimmed free
of connective tissue and transferred to RPMI-1640 medium containing
L-glutamine. The spleen and medium was poured onto a 70 μm nylon
sieve (Falcon) in a Petri dish and, using a plunger of a 5 ml syringe, the
spleen was ground until a ﬁne suspension of spleen cells was obtained.
This suspension of splenocytes was transferred to a 15 ml centrifuge
tube, using a Pasteur pipette, and allowed to stand for 10 min at room
temperature to ensure that debris and cell clumps settle to thebottomof
the centrifuge tube. The splenocytes in the supernatant were aspirated
off and transferred to a fresh 15 ml centrifuge tube. The splenocytes
were centrifuged at 300 g for 5 min in a bench-top centrifuge. The cell
pellet was re-suspended in RPMI-1640.
Cells were counted using the Trypan Blue exclusion method. 0.05 ml
of 0.1% (w/v) trypan blue, 0.03 ml RPMI-1640 (10% FBS and L-glutamine)
and 0.02 ml of cell suspension were added together and left at room
temperature for 10 min prior to counting. Cell count was performed
using a haemocytometer.
2.4. Isolation of mitochondria from thymus and spleen
Mitochondria were isolated from thymus and spleen tissues by
differential centrifugation essentially as described by Chappell and
Hansford [32]. Thymus or spleen tissues were suspended in ice-cold
(0–4 °C) buffer (250 mM sucrose, 5 mM Trizma-base, 2 mM EGTA,
pH 7.4). The cell suspensions were poured into a 2 ml Potter homog-
enizer tube to a ﬁnal volume of about 1.5 ml. The tissue suspensionswere then homogenized by hand, with 6 passes using a pestle of
0.12 inch (tight) clearance. The homogenates were centrifuged at
800 g for 3 min at 4 °C. The pellets were discarded and the
supernatants were centrifuged at 12,000 g for 10 min at 4 °C yielding
a “mitochondrial” pellet. The supernatants were discarded and the
pellets were resuspended in buffer and re-centrifuged at 12,000 g for
10 min at 4 °C. The pellets were resuspended in buffer and re-
centrifuged as above. The resulting pellets, containing the mitochon-
drial fraction, were resuspended in buffer to the desired concentration
and stored on ice prior to analysis.
2.5. Indirect immunoﬂuorescence
Isolated thymocytes were prepared for indirect immunoﬂuores-
cence essentially as described in Adams et al. [22]. Thymocytes were
suspended in Hanks medium (and 10% FBS). 0.5% (v/v) paraformal-
dehyde was added to 1 ml of thymocytes and incubated on ice for
5 min. 20 μl of cells were added to the slides (poly-l-lysine coated)
and allowed to dry (phosphate crystals form). Slides were then
dipped in (−20 °C) methanol at −20 °C for 5 min. Slides were then
dipped in (−20 °C) acetone at −20 °C for 5 min. Slides were then
allowed to dry at room temperature.
The cells on the cover-slips were then incubated with blocking
buffer (PBS containing 5% (w/v) BSA and methylamine, 0.1 M) for 2 h
at room temperature in Petri dishes, to inactivate any remaining
formaldehyde and block non speciﬁc binding. The cells on the cover-
slips were incubated with primary antibody diluted in PBS containing
5% (w/v) BSA overnight at room temperature. Followingwashingwith
PBS the cells on the cover-slips were incubated with the secondary
antibody conjugated to a ﬂour diluted with PBS for 3 h at room
temperature. The cells on the cover-slips were then washed with PBS
(and sodium azide) and ﬁnally mounted onto glass slides using 5 μl of
anti-quench solution.
2.6. Preparation of anti-quench
The anti-oxidant n-propyl gallate (4%, v/v) was dissolved in PBS
buffer containing sodium azide (15 mM) and glycerol (50%, w/v).
0.1 μg/ml Hoeschst stain was also added. This solution was always
made fresh on the day and stored at 4 °C in the dark until required.
2.7. Confocal microscopy
Confocal microscopy was performed essentially as described by
Adams et al. [21,22]. The 12 well plates with anti-quench solution
were covered with cover-slips and were afﬁxed to the glass slide by
applying a thin ﬁlm of nail varnish to the edges of the cover-slip. This
procedure also prevented the samples from drying out. The slides
were examined by phase contrast and confocal microscopy with an
Olympus Fluoview FV1000 Imaging system. The excitation light for
imaging was provided by the 457–514 nm lines of a multi-line Argon
laser, the 543 nm line of a Green Helium–Neon laser and the 633 nm
line of a red helium–Neon laser. Images were collected and processed
with the Olympus Fluoview software (version 1.3c). Thymocytes were
probed with FITC-conjugated anti-Thy1 antibody (BD Biosciences,
green) and UCP3 antibody (custom made by Eurogentec) using an
Alexa 647 labeled secondary antibody (Invitrogen-red).
2.8. Flow cytometry–cell detection
Thymocytes/splenocytes were washed and adjusted to 5×106/ml
in PBSA (1% (w/v) BSA-PBS) and 50 μl was used for each sample. Cells
were incubated on ice for 15 min in the dark with the surface staining
antibodies (CD4-FITC and CD8-R-PE). Fixation medium (Caltag A;
Invitrogen) was added to each tube, followed by incubation on ice for
15 min. Cells were washed twice in PBSA and 30000 events collected
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software.
2.9. Thymocyte incubations with dexamethasone
Thymocytes were isolated as previously described [31]. Thymo-
cytes were seeded in RPMI-1640 medium supplemented with
10% (w/v) heat-inactivated fetal bovine serum, 2 μM L-glutamine,
penicillin (100 U/ml) and streptomycin (100 μg/ml) in the presence
or absence (just vehicle, ethanol) of 0.1 μM dexamethasone for up
to six hours in a 37 °C humidiﬁed incubator under an atmosphere of
5% (v/v) CO2.
2.10. Mitochondrial protein determination using the bicinchoninic acid
assay
Quantiﬁcation of protein concentrations in mitochondrial samples
was carried out using the bicinchoninic acid assay described by Smith
et al. [33]. This measures the formation of Cu+ from Cu2+ by the
Biuret complex in alkaline solutions of protein. All of the following
solutions (standards or samples) were directly prepared in a 96-well
plate. A standard protein solution of BSA was suitably diluted in
deionized water from 0 to 0.25 mg.ml−1. The amount of mitochon-
drial protein present in the samples was determined by reference to a
standard curve derived from the above known concentrations of BSA.
Isolated mitochondria were diluted in H2O before analysis to ensure
the ﬁnal concentration of the samples would fall within the range of
the standard curve. Once the samples and the standards were
prepared, 200 μl of a working solution of BCA (1:49 (v/v) BCA:
Cu2SO4) was added to each well. The plate was then incubated for
30 min in an incubator set at 37 °C. The absorbance of each sample
was measured spectrophotometrically at 550 nm.
2.11. SDS-PAGE and Western Blot analysis
One-dimensional SDS-PAGE under reducing conditions was used
to separate proteins prior to immunoblot analysis, as described by
Cunningham et al. [2]. Following SDS-PAGE, resolved proteins were
transferred onto polyvinylidene diﬂuoride (PVDF) membranes
(Immobilin-PSQ; Millipore) as described by Cunningham et al. [2].
the anti-UCP3 polypeptide antibody (amino acids 141–156) was
custom made by Eurogentec as previously reported. The pyruvate
dehydrogenase (PDH) E1α monoclonal antibody was from Mitos-
ciences. The primary antibodies were all used at 1:1000 dilution.
Following blocking and overnight primary antibody incubation, the
blots were incubated with a horseradish peroxidase-conjugated goat
anti-rabbit secondary antibody (1:10000) in Tris-buffered saline
(TBS), 0.5% (v/v) Tween 20, 5% (w/v) bovine serum albumin for 1 h at
room temperature. Blots were developed using an ECL detection
system (Amersham Biosciences), and immunoreactions were visual-
ized by exposure to Kodak X-Omat LS ﬁlm.
2.12. Densitometry
Following immunoblot analysis, the relative abundance to protein
was determined using densitometry. The band intensities of the
exposed ﬁlm were analyzed using Scion Imaging Software.
2.13. Thymocyte/splenocyte induction of apoptosis
Thymocytes/splenocytes were seeded in RPMI-1640 medium
supplemented with 10% (w/v) heat-inactivated fetal bovine serum,
2 μM L-glutamine, penicillin (100 U/ml) and streptomycin (μg/ml)
either in the presence of 0.1 μM dexamethasone dissolved in ethanol
or ethanol alone (vehicle) for up to 20 h in a 37 °C humidiﬁed
incubator under an atmosphere of 5% (v/v) CO2.2.14. Flow cytometry FITC-annexin V/propidium iodide (PI) staining
The apoptotic potential of isolated thymocytes treated with
vehicle or dexamethasone was measured as follows: to determine
early membrane and DNA changes, whole thymocytes were stained
with FITC-conjugated annexin V and propidium iodide (PI) according
to manufacturer's instructions (Molecular Probes). Cells (0.75×106)
were suspended in 100 μl of annexin-binding buffer, and 5 μl of FITC-
annexin V and 1 μl of PI (100 μg/ml) was added to each 100 μl cell
suspension. Cells were incubated for 15 min at room temperature.
Stained cells were suspended in 400 μl of binding buffer and
immediately processed by ﬂow cytometry.
2.15. Measurement of oxygen consumption rates of cells
All measurements of oxygen consumption rate were made using an
Oxygraph-2k respirometer (Oroboros Instruments, Innsbrück, Austria),
and oxygen ﬂuxwas resolved using DATLAB software. The oxygraph-2k
is a two chamber titration–injection respirometerwith a limit of oxygen
ﬂux detection of 1 pmol/ml−1. Standardized instrumental and chemical
calibrations were performed to correct for back diffusion of oxygen into
the chamber from the various components; leak from the exterior,
oxygen consumption by the chemical medium, and sensor oxygen
consumption. The cell suspension was stirred using a PDVF magnetic
stirrer and thermostatically maintained at 28 °C. Before each experi-
ment mediumwas equilibrated for 30–40 min with air in the oxygraph
chambers until a stable signal was achieved to calibrate for oxygen
saturation.Quiescent cell steady state oxygen consumption rates (basal)
were then measured in RPMI medium (5×106 cells/ml). Subsequent
additions included sufﬁcient oligomycin (60 ng/ml) to inhibit in situ
mitochondrial ATP synthase and reﬂect the oxygen due to the proton
leak of the in situ mitochondria (leak) and themitochondrial uncoupler
carbonylcyanide-4-(triﬂuoromethoxy)-phenylhydrazone (100 nM
FCCP) was added to determine the maximal electron chain activity of
the in situ mitochondria, as described in Buttgereit and Brand [31]. ATP
levels in thymocytes fromWT and UCP3 komiceweremeasured from a
single experiment in triplicate as per Adams et al. [22] but no difference
in ATP levels were detected (results not shown).
2.16. Statistical analysis
All results are expressed as mean±sem of ‘n’ determination
performed in at least triplicate unless otherwise indicated. Mean
values were compared using an unpaired student's t-test test. Unless
otherwise stated a p value of≤0.05 was taken to indicate signiﬁcance.
3. Results
Fig. 1 shows the selectivity of the peptide antibody raised to UCP3.
The UCP3 antibody detects UCP3 in both lysates from yeast over-
expression UCP3 (Fig. 1A and C) and mitochondria isolated from
thymus (Fig. 1A) and spleen (Fig. 1C) of wild-type mice. No UCP3 was
detected in UCP3 knockout mice or in mouse liver mitochondria, as
expected (Fig. 1A and C). The presence of mitochondria was
conﬁrmed using an antibody to pyruvate dehydrogenase subunit
E1α (Fig. 1B and D). These data are consistent with selectivity and
sensitivity determinations using this antibody previously reported by
Cunningham et al. [2].
We have previously used confocal images of thymocytes to
demonstrate expression of UCP1 [21,22]. Here we have used confocal
microscopy to demonstrate constitutive UCP3 expression in thymo-
cytes. Fig. 2 shows a comparison of thymocytes from wild-type and
UCP3−/− mice. The images show (a) localization of the nucleus
within thymocytes fromwild-type and UCP3−/−mice using Hoechst
stain (b) the labeled surface marker Thy 1 (green) used to identify
thymocytes from wild-type and UCP3−/− mice, (c) that UCP3 is
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Fig. 1. Detection of UCP3 in thymus and spleen mitochondria. Our polyclonal peptide antibody raised to UCP3 (custom made by Eurogentec and previously characterized in
Cunningham et al. [2]) detects UCP3 in both lysates from yeast over-expressing UCP3 (A) and (C) and mitochondria isolated from thymus (A) and spleen (C) of wild-type mice. No
UCP3 was detected in UCP3 knockout mice or in mouse liver mitochondria, as expected (A) and (C). An independent marker of mitochondria in (B) thymus and (D) spleen
preparations was conﬁrmed using an antibody to pyruvate dehydrogenase subunit E1α (Mitosciences).
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isolated from UCP3−/−mice, as detected using the peptide antibody
shown to be speciﬁc for UCP3 and a secondary antibody conjugated to
Alexa 647 (red) and (d) phase contrast images of thymocytes form
wild-type and UCP3−/− mice.
Fig. 3 shows the time-dependent proﬁle of UCP3 expression in
mitochondria isolated from thymus and spleen of wild-type mice
aged 1, 2, 3, 4, 6, 8 and 16 weeks. Fig. 3A and D are immunoblots
showing the anti-UCP3 peptide antibody detecting UCP3 protein in
thymus and spleen mitochondria, but not liver mitochondria (as
expected), from mice of different ages. Fig. 3B and E shows that any
variance in the expression of UCP3, due to age, cannot be due to
differences in lane loading, as indicated by immunoblot with the
antibody to PDH-E1-α. Fig. 3C and F shows the collated data, from
immunoblots, for thymus and spleen mitochondria, respectively, and
the abundance of UCP3 protein expression, relative to PDH for 3
separate experiments. A signiﬁcant reduction in UCP3 expression
occurs after 3 weeks and persists in mitochondria from thymus
(p=0.0024). A signiﬁcant increase in UCP3 in spleen mitochondria
expression occurs between weeks 1 and 3 (p=0.02, n=3) and
between weeks 2 and 3 (p=0.03, n=3). A signiﬁcant reduction in
UCP3 expression occurs between weeks 3 and 4 (p=0.02, n=3) and
persists from then on.DAPI Thy1
DAPI
Wild-type
UCP3 k.o.
Thy1
Fig. 2. Confocal microscopy images of UCP3 in thymocytes fromwild-type and UCP3 knock-o
and UCP3 knock-out mice using Hoechst stain the labeled surface marker Thy 1 (green), UCP
Alexa 647 (red) and phase contrast images of thymocytes from wild-type and UCP3−/− mFig. 4 shows that following 24-hour fasting, UCP3 protein expression
is increased in mitochondria isolated from the thymus, but not spleen
mitochondria of 129 wild-type mice when compared to fed controls.
The UCP3 peptide antibody detects UCP3, in mitochondria of thymus
(Fig. 4A) and spleen (Fig. 4D), in lysates of yeast over-expressing UCP3,
but not in liver mitochondria, as expected. Fig. 3B and E shows that any
variance in the expression of UCP3 cannot be due to differences in lane
loading, as indicatedby anantibody toPDH-E1-α (Mitosciences). Fig. 4C
and F shows the collated immunoblot data for thymus and spleen
mitochondria, respectively, as determined by densitometry, and the
relative abundance of UCP3 protein expression as a ratio to PDH
for 3 separate experiments. There is a signiﬁcant (p=0.001) increase
(~3-fold) in UCP3 expression in thymus mitochondria isolated from
starved animals compared to fed controls. There is no signiﬁcant
difference in UCP3 expression in spleen mitochondria isolated from
starved animals compared to fed controls.
Fig. 5 illustrates that there is no signiﬁcant difference in thymus
weight in a comparison of thymi from wild-type and UCP3 knock-out
mice either in the fed or fasted state (Fig. 5A). However there is a
signiﬁcant reduction (p=0.016) in thymus mass due to 24 h starva-
tion of wild-type fed mice compared to wild-type fasted animals
(Fig. 5A). There is also a signiﬁcant reduction in the thymus mass of
starved UCP3 knock-out mice compared to fed UCP3 knock-out miceUCP 3 Phase Contrast
Phase ContrastUCP 3
ut mice. The images show localization of the nucleus within thymocytes fromwild-type
3 detected using our peptide antibody for UCP3 and a secondary antibody conjugated to
ice. Bar is 5 μm.
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mass in a comparison of spleens from wild-type and UCP3 knock-out
mice in the fed state (Fig. 5B). However, there is a signiﬁcant
(p=0.002) 1.25-fold reduction in spleen mass in the absence of UCP3
in the fasted state (Fig. 5B). 24 h starvation had no signiﬁcant effect on
spleen mass of wild-type fed mice compared to wild-type fasted
animals (Fig. 5B) or in the spleen mass of starved UCP3 knock-out
mice compared to fed UCP3 knock-out mice (Fig. 5B). We also
observed no signiﬁcant difference between the total cell count in the
spleen of wild-typemice compared to UCP3 knock-out mice in the fed
state (Fig. 5D). However there is a signiﬁcant (p=0.004) 1.25-fold
reduction in the number of splenocytes in the fasted state (Fig. 5D) of
wild-type mice compared to UCP3 knockout mice. Furthermore, 24 h
starvation caused a signiﬁcant reduction (p=0.05) in total spleen cell
number in wild-type mice (Fig. 5D), and in UCP3 knock-out mice
(Fig. 5D) (p=0.004).
Fig. 6A and B demonstrates a comparison of oxygen consumption
rates by thymocytes and splenocytes isolated fromwild-type and UCP3
knock-out mice. Rates were measured for quiescent cells (basal), cells
that were treated with oligomycin, thus inhibiting the mitochondrial
ATP synthase, resulting in reduced oxygen consumption rates predom-
inantly due to proton leak (leak) and in the presence of a mitochondrial
uncoupler, thus giving maximal mitochondrial oxygen consumption
(FCCP). Interestingly, no signiﬁcant differences were observed in the
aforementioned comparisons. Furthermore, starvation had no signiﬁ-
cant effect on these in vitro oxygen consumption rates for the afore-
mentioned comparisons (Fig. 6C and D).
Fig. 7A–F displays the proportion of thymocytes that are CD4 single
positive (CD4SP), CD8 single positive (CD8SP), CD4CD8 double negative
(DN) and CD4CD8 double positive (DP) in a comparison of wild-type
and UCP3 knock-out (UCP3−/−) mice in the fed state. The data
demonstrates that there is a signiﬁcant (2.5-fold, p=0.0001) reduction
in the abundance of CD4 single positive (Fig. 7A) and a signiﬁcant (1.4-
fold, p=0.0001) reduction in CD4CD8 double negative cells (Fig. 7E) in
the thymi of UCP3 knock-out mice compared to that of wild-type
controls. No signiﬁcant reduction in CD8SP (Fig. 7D) or DP cell (Fig. 7F)subsets were observed in thymi from UCP3 knock and wild-type
mice. Representative dot-plots for thymocytes from fed wild-type and
UCP3−/− are shown (Fig. 7A and B). Fig. 7 G–L displays the proportion
of thymocytes that are CD4SP, CD8SP, DN and DP in a comparison of
wild-type and UCP3 knock-out mice in the fasted state. The data
demonstrates that there is a signiﬁcant (1.25-fold, p=0.007) reduction
in the abundance of CD4 SP (Fig. 7I), and a signiﬁcant decrease in the
CD8SP cell number (Fig. 7J) (1.3-fold, p=0.0005) in the thymi of UCP3
knock-out mice compared to that of wild-type controls. No signiﬁcant
reduction in DN (Fig. 7K) or DP cell subsets was observed in thymi from
UCP3 knock-out and wild-type mice, if anything there was a slight
increase in DP in UCP3 knock-out mice compared to wild-type controls
(Fig. 7L). Representative dot-plots for thymocytes from fastedwild-type
and UCP3−/− are shown (Fig. 7G and H).
Comparing the data from the fed and fasted states and whether
there is any effect on the relative proportion of thymocyte subsets
from UCP3 knock-out and wild type mice it would appear that
starvation attenuates differences in the abundance of CD4SP (Fig. 7C
and I) and DN (Fig. 7E and K). Starvation has no effect on the
proportions of DP cell (Fig. 7F and L), but result in a signiﬁcant
(p=0.0005) 1.3-fold reduction in the proportion CD8SP cells (Fig. 7D
and J) in UCP3 knock-out mice compared to wild-type control mice.
Comparing the data for the effect of starvation on the relative
proportion of thymocytes from wild-type mice, it appears there is a
30% increase in the proportion of CD4SP cells in wild-type mice
(Fig. 7C and I, p=0.00031), a 50% increase in the number of CD8SP in
wild-type mice (Fig. 7D and J, p=0.001), a 42% increase in proportion
of DN (Fig. 7E and K, p=0.004) and a 6% decrease in the proportion of
DP cells in wild-type mice (Fig. 7F and L, p=0.003) in wild-type
animals. The effect of starvation on UCP3 knock-out mice saw a 2.3-
fold increase (p=0.001) in CD4SP cells (Fig. 7C and I), no signiﬁcant
effect on CD8SP (Fig. 7D and J) or DN cells (Fig. 7E and K), and a small
4% reduction in DP (Fig. 7F and L, p=0.015) in a comparison of fed
and starved UCP3 knock-out mice.
Fig. 8A–F displays the relative proportion of splenocytes, in a
comparison of wild-type and UCP3 knock-out (UCP3−/−) mice in the
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lymphocyte and other cells (including monocytes, natural killer
cells, B-lymphocytes). The data demonstrates that there is a
signiﬁcant (p=0.0001) 2-fold increase in the abundance of CD4SP
(Fig. 8C), 2-fold increase in the abundance of CD8SP (Fig. 8D,
p=0.0001) and 2-fold increase in the abundance of DP (Fig. 8F
p=0.0001) in the spleens of UCP3 knock-out mice compared to wild-
type controls. There is small but signiﬁcant (p=0.0006) increase in
the amount of “other cells” in wild-type compared to UCP3 knock-out
mice (Fig. 8E). Representative dot-plots for splenocytes from fedwild-
type and UCP3−/− are shown (Fig. 8A and B). Fig. 8G–L displays the
proportion of splenocytes, that are CD4SP lymphocytes, CD8SP
lymphocytes, DP lymphocyte and other cells (including monocytes,
natural killer cells, B-lymphocytes), in a comparison of wild-type and
UCP3 knock-out mice in the fasted state. The data demonstrates that
there is a signiﬁcant (p=0.02) 2-fold decrease in the relative
abundance of DP cells in UCP3 knock-out mice compared to wild-
type controls (Fig. 8L), with no signiﬁcant difference in the relative
abundance of CD4SP (Fig. 8I), CD8SP (Fig. 8J), and other cells (Fig. 8K)
in wild-type compared to UCP3 knock-out mice. Representative dot-
plots for splenocytes from fasted wild-type and UCP3 knock-out mice
are shown (Fig. 8G and H).
Comparing the data from the fed and fasted states and whether
there is any effect on the relative proportion of splenocyte subsets
from UCP3 knock-out and wild type mice it would appear that
starvation attenuates any aforementioned differences in the abun-
dance of CD4SP (Fig. 8C and I), CD8SP (Fig. 8D and J) and other cells
(Fig. 8E and K), while causing a 4-fold swing (Fig. 8F and L) in the
proportion on DP cells in UCP3 knock-outmice compared towild-type
control mice.Comparing the data for the effect of starvation on the relative
proportion of splenocytes from wild-type mice, it appears there is a
doubling in the proportion of CD4SP cells in wild-type mice (Fig. 8C
and I p=0.001), a quadrupling in the number of CD8SP in wild-type
mice (Fig. 8D and J, p=0.001), an approximate tripling of the
proportion of other cells (Fig. 8E and K, p=0.0006) and a tripling in
the proportion of DP cells in wild-type mice (Fig. 8F and L, p=0.001)
in wild-type animals. The effect of starvation on UCP3 knock-out mice
was less marked, with no signiﬁcant effect on the proportion of CD4SP
(Fig. 8C and I), CD8SP (Fig. 8 and J) and other cells (Fig. 8E and K), but
a 50% reduction in DP (Fig. 8F and L, p=0.02) in a comparison of fed
and starved UCP3 knock-out mice.
We conclude that lack of UCP3 affects the relative abundance of all
splenocyte subsets compared to those from wild-types, that starva-
tion attenuates these differences and that starvation has a more
marked effect on the proportion of splenocyte subsets from wild-type
than it does from mice lacking UCP3.
Fig. 9A and B compares the relative percentage apoptosis occurring
in thymocytes isolated from 3 week old wild-type mice and 3 week
old UCP3 knock-out mice after 5 hour treatment with 1 μM dexa-
methasone or vehicle (ethanol). There is no signiﬁcant difference in
the extent of apoptosis in dexamethasone-treated thymocytes
isolated from fed UCP3 knock-out mice or fed wild-type mice
(Fig. 9A). However, the level of spontaneous apoptosis occurring in
the thymocytes of fed wild-type mice is 1.3-fold less than in the
thymocytes from fed UCP3 knock-out mice (p=0.05)(Fig. 9A).
Starvation did not manifest any signiﬁcant difference in the extent
of apoptosis in dexamethasone-treated thymocytes isolated from fed
UCP3 knock-out mice or fed wild-type mice (Fig. 9B). However, the
level of spontaneous apoptosis occurring in the thymocytes of fasted
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fed UCP3 knock-out mice (p=0.003) (Fig. 9B). Analysis of apoptosis
in thymocytes from starved animals revealed a dramatic increase in
the apoptotic potential of the thymocytes from both wild-type and
UCP3 knock-out mice, with an approximate 3-fold increase in
apoptosis following dexamethasone treatment in thymocytes from
wild-type and UCP3 knock-out mice (Fig. 9A and B), and an
approximate 4–5-fold increase in apoptosis in thymocytes from
wild-type and UCP3 knock-out mice treated with vehicle (Fig. 9A and
B). However, the relative proportion of cells undergoing apoptosis, in
the fed and fasted states, in a comparison of wild-type and UCP3
knock-out mice was not affected by starvation. No signiﬁcant
differences were observed in caspase 3 or caspase 7 activity in a
comparison of thymocytes from wild-type or UCP3 knock-out mice,
either in the presence of dexamethosone or vehicle after 5 h (results
not shown). Similar data to those already detailed for measurements
at 5 h on the relative proportion of thymocytes undergoing apoptosis
were observed for splenocytes incubated for 18 h (results not shown).
Fig. 9C and D compares the relative percentage apoptosis occurring
in all splenocytes isolated from 3 week old wild-typemice and 3 week
old UCP3 knock-out mice after 5 hour treatment with 1 μM dexa-
methasone or vehicle (ethanol). There is no signiﬁcant difference in
the extent of apoptosis in dexamethasone-treated thymocytes
isolated from fed UCP3 knock-out mice or fed wild type mice
(Fig. 9C). Similarly, the level of spontaneous apoptosis occurring in
the splenocytes of fed wild-type mice is only 1.4-fold greater than in
the splenocytes from fed UCP3 knock-out mice (p=0.005) (Fig. 9C).
Analysis of apoptosis in splenocytes from starved animals revealed an
increase in the apoptotic potential of the splenocytes from both wild-
type and UCP3 knock-out mice, with an approximate 2-fold increasein apoptosis following dexamethasone treatment in splenocytes from
wild-type and a 2.5-fold increase in UCP3 knock-out mice (Fig. 9C and
D), and an approximate 4–5-fold increase in apoptosis in splenocytes
fromwild-type and UCP3 knock-outmice treated with vehicle (Fig. 9C
and D). However, the relative proportion of cells undergoing
apoptosis, in the fed and fasted states, in a comparison of wild-type
and UCP3 knock-out mice was affected by starvation following drug
treatment, with 1.25-fold increase in dexamethasone treated cells
(Fig. 9C versus D). There was no real change in the relative proportion
of cells from wild-type and UCP3 knock-out mice undergoing
apoptosis in vehicle treated cells (Fig. 9C versus D).
Similar data on the relative proportion of splenocytes undergoing
apoptosis were observed for splenocytes incubated for 18 h (results
not shown).
4. Discussion
Our data in Fig. 1 demonstrate that UCP3 is present in both thymus
and spleen mitochondria of mice. These data endorse data previously
reported, by us, for the presence of UCP3 in thymus and spleen of rats
[2], and emphasize the selectivity of our antibody to UCP3 over other
mitochondrial transporters/proteins. The selectivity of the antibody is
further emphasized by the demonstration of UCP3 in thymocytes
from wild-type mice with no detection in UCP3 knock-out mice
(Fig. 2). Furthermore, UCP3 is present in mitochondria of thymus and
spleen up to at least 16 weeks after birth (Fig. 3). Interestingly, levels
of UCP3 drop by about a half in thymus and a ﬁfth in spleen after three
weeks, as reﬂected in their mitochondria. This time period coincides
with a switch by mice from suckling to weaning, and the reduction in
UCP3 level most probably reﬂects this change, with the interesting
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than weaning. Similar observations were made at this same time
period for constitutively expressed UCP1 in thymus mitochondria
[22].
UCP3 has long been associated with lipid metabolism [7] and there
have been several reports in the literature demonstrating that UCP3
protein expression increases in skeletal muscle on starvation of
animals [2,5]. In this study, we observed that UCP3 expression was
starvation sensitive in mouse thymus, increasing ~3-fold per unit
mass of mitochondria (Fig. 4). However, UCP3 expression was
unaffected by starvation in spleen of mouse (Fig. 4), although there
may be a moderate fractional increase in UCP3 in the T-lymphocyte
subset as reﬂected in rat [14]. So clearly there is a differential
sensitivity of UCP3 to starvation in thymus and spleen.
Despite the absence of UCP3 in knock-out mice there is no
signiﬁcant difference in thymus weight in a comparison with thymi
from wild-type mice in the fed state and or fasted state (Fig. 5).
However, as has been previously reported [34], there is a signiﬁcant
reduction in thymusmass due to starvation in wild-typemice and this
holds true for UCP3 knock-out mice also. The lack of difference in
thymus mass in a comparison of wild-type mice and UCP3 knock-out
mice, yet a reduction in thymus mass on starvation, is also reﬂected at
the level of total cell abundance. A similar picture emerges for spleens
of UCP3 knock-out mice in that there is no signiﬁcant difference in
spleen mass in a comparison of the thymi from wild-type in the fed
state (Fig. 5). However, there is a signiﬁcant modest reduction in
spleen mass in the absence of UCP3 in the fasted state. Starvation had
no signiﬁcant effect on spleen mass of wild-type fed mice nor was
there a reduction in the spleen mass of starved UCP3 knock-out mice.
The proﬁle with regard to spleen mass is also reﬂected at the cell
number level.
Using oxygen consumption as an index of cellular metabolism and
mitochondrial functionweobservednoapparent effect of the absence of
UCP3 on total thymocyte or splenocyte oxygen consumption rates, or
oxygen consumption rates due to proton leak, and fasting the animals
had no effect of the aforementioned comparisons (Fig. 6). If UCP3was to
have an effect on cellular metabolism, as measured in vitro, under the
conditions deﬁned here, one might expect any potential difference
between cells from wild-type and UCP3 knock-outs or between cells
from wild-type from fed and fasted animals to be manifest in the
comparisons. Having said that, there may have been an effect of the
absence of UCP3 on thymocytes or splenocytes in vivo whichmay have
been lost in our subsequent in vitro oxygen consumption analysis.
While not reﬂected as a difference in total cell numbers (Fig. 5),
there does appear to be a difference in the proportional of certain
subsets of thymocytes as a result of the lack of UCP3 compared to
those from wild-types in the fed state (Fig. 7). Lack of UCP3 manifests
as reduced CD4+ single positive cells and reduced double negative
cells in the thymus, but these differentials are not exacerbated by
starvation. However, starvation does increase the proportion CD8+ in
animals in wild-types compared to UCP3 knock-out mice (Fig. 7).
Again, there does appear to be a difference in the proportion of certain
subsets of thymocytes as a result of starvation within wild-type and
UCP3 groups without a difference in total cell numbers. Within wild-
type mice starvation results in an increase in the proportion of the
smaller subsets namely CD4SP, CD8SP and DN cells which in turn are
offset by a 6% decrease in the proportion of the most predominant DP
cells. In UCP3 knock-out mice after starvation we observed a different
proﬁle with a signiﬁcant increase in CD4SP cells only, which in turn
was offset by and a small reduction in most prevalent DP cells (Fig. 7).
Overall we can conclude that UCP3 does affect thymocyte cell proﬁle
in the fed and fasted state.
Lack of UCP3 in the spleen of fed animals manifests as a 2-fold
increase in the proportion of CD4+, CD8+ and DP cells (Fig. 8) and
this is against a backdrop of no signiﬁcant difference in total cell
numbers (Fig. 6). Starvation attenuates these proportionate differ-ences in a comparison of wild-type and UCP3 knock-out mice (Fig. 8)
while causing a 4-fold swing in the proportion on DP cells in the
spleen of UCP3 knock-out mice compared to wild-type control mice.
Clearly any changes in the proportion of cell populations in the spleen
in wild-type versus UCP3 knock-out animals as a result of starvation
must directly result from changes in the thymus as UCP3 abundance is
unaffected by starvation in the spleen but is affected in the thymus
and T-lymphocytes in the spleen originate from the thymus. The
consequence is a greater proportion of double positive cells in the
periphery (spleen) which is indicative of a processing alteration/
problem in the thymus of UCP3 knock-out mice.
Furthermore, starvation has a much more dramatic effect on wild-
type mice splenocyte proﬁle than on that of UCP3 knock-out mice
(Fig. 8). While in wild-type mice starvation increased CD4SP, CD8SP,
DP and other cells, the effect of starvation on UCP3 knock-out mice
was less marked, with no signiﬁcant effect on the proportion of
CD4SP, CD8SP, and other cells and a reduction in DP (Fig. 8). We
conclude that lack of UCP3 affects the relative abundance of all
splenocyte subsets compared to those from wild-types, that starva-
tion attenuates these differences and that starvation has a more
marked effect on the proportion of splenocyte subsets from wild-type
than it does from mice lacking UCP3. Furthermore, the difference in
the splenocyte proﬁles in a comparison of fed and fasted wild-type
mice must be as a result of UCP3 manifesting its effect in the thymus
as UCP3 abundance is unaffected by starvation in the spleen, but is
affected in the thymus and T-lymphocytes in the spleen originate
from the thymus.
As apoptosis is a prevalent event in thymus in both positive and
negative selection processes for thymocytes, we compared the
apoptotic potential of thymocytes lacking UCP3 with thymocytes
from wild-type mice (Fig. 9). The observations of increased apoptotic
potential with vehicle alone, in UCP3 knock-out mice relative to wild-
typemice in both fed and fasted state, are reﬂected in the tendency for
a decreased splenocyte cell number in the fed state and the signiﬁcant
decrease in splenocyte numbers after starvation (Fig. 6), because no
signiﬁcant difference in the thymus cell numbers are evident (Fig. 5).
Clearly splenocytes from UCP3 knock-out mice are more resistant to
apoptosis with vehicle alone in the fed state, andwith dexamethasone
and vehicle in the fasted state, than those from wild-type mice
(Fig. 9), however therewas no real difference in the proportion of cells
undergoing apoptosis in wild-type versus UCP3 knock-out mice in the
transition from fed to fasted state. So we conclude that UCP3 has an
impact on apoptotic potential splenocytes, but the UCP3 dependent
effect is not exacerbated by starvation.What is strikingly evident from
the data in Fig. 9 is the dramatic increase in apoptosis of thymocytes
and splenocytes upon starvation of the wild-type or UCP3 knock-out
animals.
There have been two other studies looking at the effect on UCP
ablation of thymocyte proﬁle. Krauss et al. [26] observed no signiﬁcant
differences on thymocyte proﬁle in a comparison of wild-type and
UCP2 knock-out mice (in the fed state). Adams et al. [22]
demonstrated an ~3-fold reduction in spleen cell numbers, a halving
of CD8 single positive cell numbers in thymus and a signiﬁcant
incremental increase in CD4/CD8 double positive cell numbers in UCP
1 knock-out mice compared to wild-type mice (in the fed state). In a
comparison of wild-type and UCP3 knock-out mice none of the
aforementioned parameters were affected, indicating different roles
for UCP1 and UCP3 in thymus. On the other hand, in spleens of UCP1
knock-out mice there was an approximate halving of CD8 single
positive cell numbers and a doubling of CD4/CD8 double positive cell
numbers compared to wild-type mice. In this study conversely to the
former, we see a doubling of CD8 single positive cells, but consistent
with the latter we see a doubling of CD4/CD8 double positive cells in
UCP3 knock-out mice compared to wild-types.
We conclude that constitutively expressed UCP3 is a factor in
determining T-cell population selection in mice.
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